Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A model binding site for testing scoring functions in molecular docking.

Binqing Q Wei1, Walter A Baase, Larry H Weaver

  • 1Department of Molecular Pharmacology and Biological Chemistry, Northwestern University School of Medicine, Chicago, IL 60611-3008, USA.

Journal of Molecular Biology
|September 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling the Sensitivity of Large-Scale Virtual Screening to Scoring Function Accuracy, Artifacts, and Library Composition.

Journal of chemical information and modeling·2026
Same author

Library Docking for Cannabinoid-2 Receptor Ligands.

Journal of medicinal chemistry·2026
Same author

In-depth multimodal validation of <sup>18</sup>F-THK5351 for imaging monoamine oxidase-B-mediated reactive astrogliosis in Alzheimer's and related neurodegenerative diseases.

Experimental & molecular medicine·2026
Same author

Toward a Random Background for Ligand Optimization.

bioRxiv : the preprint server for biology·2026
Same author

The Selectivity Implications of Docking Libraries with Greater and Lesser Similarities to Bio-like Molecules.

Journal of medicinal chemistry·2026
Same author

Drug-Induced Phospholipidosis as an Artifact in Antiviral Drug Repurposing.

ACS omega·2026

Accurate atomic charges and solvation energies improve molecular docking predictions for drug discovery. This study demonstrates enhanced ligand ranking and binding site distinction using T4 lysozyme mutants, validating improved computational methods.

Area of Science:

  • Computational Chemistry
  • Structural Biology
  • Drug Discovery

Background:

  • Predicting ligand-receptor interaction energies is crucial for structure-based inhibitor discovery.
  • Existing scoring functions require robust testing with well-characterized experimental systems.
  • The quality of atomic charges and solvation energies significantly impacts molecular docking accuracy.

Purpose of the Study:

  • To investigate the effect of improved atomic charges and solvation energies on molecular docking.
  • To evaluate the performance of new computational methods using engineered binding sites in T4 lysozyme.
  • To assess the predictive value of enhanced docking calculations for ligand binding.

Main Methods:

  • Calculated atomic charges and solvation energies for 172,118 molecules using AMSOL (a semi-empirical quantum mechanical approach).

Related Experiment Videos

  • Screened a chemical database against apolar (L99A) and polar (L99A/M102Q) T4 lysozyme binding sites.
  • Determined X-ray crystal structures for five ligand-bound L99A/M102Q complexes and compared with docking predictions.

    • Main Results:

    • New charges and desolvation energies improved the ranking of known apolar ligands and distinguished them from polar isosteres.
    • Docking predictions for the polar binding site showed high correlation with experimental results (0.4Å RMSD).
    • Seven tested polar molecules preferentially docked to the polar cavity and experimentally bound, but not to the apolar cavity.

    Conclusions:

    • Improved treatment of partial atomic charges and desolvation energies enhances database docking performance.
    • The study validates the use of engineered T4 lysozyme binding sites for developing and testing docking algorithms.
    • Accurate computational methods lead to better distinction of true ligands and improved inhibitor discovery.